Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Targeted Inhibition of Phosphodiesterase (PDE) 4 As a Novel Therapy to Increase Endothelial Cell cAMP and Trigger Weibel Palade Body Exocytosis

Dearbhla Doherty, Ellie Karampini, Ciara Byrne, Ingmar Schoen, Roger J.S Preston, Jamie M O'Sullivan, Michelle Lavin, James O'Donnell

Blood (2023) 142 (Supplement 1): 3975.

https://doi.org/10.1182/blood-2023-178581

Published: 2023

Journal Articles

Primary Myeloma Cell Induced Von Willebrand Factor Release from the Endothelium Is Mediated By VEGF and Attenuated By Heparin

Claire Comerford, Sukhraj Pal Singh Dhami, Philip Murphy, Sean Patmore, Siobhan Glavey, John Quinn, Jamie M. O'Sullivan

Blood (2021) 138 (Supplement 1): 3141.

https://doi.org/10.1182/blood-2021-149134

Published: 2021

Journal Articles

The relationship between ABO blood group, von Willebrand factor, and primary hemostasis

Soracha E. Ward, Jamie M. O’Sullivan, James S. O’Donnell

Blood (2020) 136 (25): 2864–2874.

https://doi.org/10.1182/blood.2020005843

Published: 2020

Journal Articles

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib

Jennifer M. O’Sullivan, Angela Hamblin, Christina Yap, Sonia Fox, Rebecca Boucher, Anesh Panchal, Samah Alimam, Helene Dreau, Kieran Howard, Pauline Ware, Nicholas C. P. Cross, Mary Frances McMullin, Claire N. Harrison, Adam J. Mead

Blood (2019) 134 (23): 2107–2111.

https://doi.org/10.1182/blood.2019001861

Published: 2019

Includes: Supplemental data

Journal Articles

von Willebrand factor promotes wound healing

James S. O’Donnell, Jamie M. O’Sullivan

Blood (2019) 133 (24): 2553–2555.

https://doi.org/10.1182/blood.2019001175

Published: 2019

Journal Articles

Increased galactose expression and enhanced clearance in patients with low von Willebrand factor

Sonia Aguila, Michelle Lavin, Niall Dalton, Sean Patmore, Alain Chion, George D. Trahan, Kenneth L. Jones, Catriona Keenan, Teresa M. Brophy, Niamh M. O’Connell, Kevin Ryan, Mary Byrne, Margaret Nolan, Anjali Patel, Roger J. S. Preston, Paula James, Jorge Di Paola, Jamie M. O’Sullivan, James S. O’Donnell

Blood (2019) 133 (14): 1585–1596.

https://doi.org/10.1182/blood-2018-09-874636

Published: 2019

Includes: Supplemental data

Journal Articles

Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function

Eimear Dunne, Qin M. Qi, Eric S. Shaqfeh, Jamie M. O’Sullivan, Ingmar Schoen, Antonio J. Ricco, James S. O’Donnell, Dermot Kenny

Blood (2019) 133 (12): 1371–1377.

https://doi.org/10.1182/blood-2018-06-855528

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Defining the Molecular Mechanisms through Which the Macrophage Galactose Lectin (MGL) Receptor Regulates Von Willebrand Factor Clearance

Soracha E Ward, BSc, Jamie M O'Sullivan, Sonia Aguila Martinez, BSc, PhD, Clive Drakeford, BSc, Thomas Anthony Jude McKinnon, BSc, PhD, Alain Chion, BSc, PhD, James S O'Donnell, MD PhD

Blood (2018) 132 (Supplement 1): 980.

https://doi.org/10.1182/blood-2018-99-114775

Published: 2018

Journal Articles

Site-Directed Pegylation at Specific Sites Significantly Prolongs the Half-Life of A1A2A3-VWF By Markedly Attenuating LRP1-Mediated Clearance

Jamie M O'Sullivan, Judicael Fazavana, PhD, Alain Chan, PhD, Niamh Cooke, PhD, Virginie Terraube, Justin Cohen, PhD, Debra D Pittman, MS, Orla Cunningham, PhD, Matthew Lambert, James S O'Donnell, MD PhD

Blood (2018) 132 (Supplement 1): 1165.

https://doi.org/10.1182/blood-2018-99-114966

Published: 2018

Journal Articles

The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

Dearbhla Doherty, MB, MRCPI, Anjali Patel, Margaret Nolan, Mary Byrne, Sonia Aguila, PhD, Jamie M O'Sullivan, Kevin Ryan, MB, FRCPath, Niamh M O'Connell, MB, PhD FRCPath, Michelle Lavin, MB, PhD FRCPath, James S O'Donnell, MD PhD

Blood (2018) 132 (Supplement 1): 1178.

https://doi.org/10.1182/blood-2018-99-115946

Published: 2018

Journal Articles

Platelets in malaria pathogenesis

Jamie M. O’Sullivan, James S. O’Donnell

Blood (2018) 132 (12): 1222–1224.

https://doi.org/10.1182/blood-2018-08-865618

Published: 2018

Journal Articles

A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance

Soracha E. Ward, Jamie M. O’Sullivan, Clive Drakeford, Sonia Aguila, Christopher N. Jondle, Jyotika Sharma, Padraic G. Fallon, Teresa M. Brophy, Roger J. S. Preston, Paul Smyth, Orla Sheils, Alain Chion, James S. O’Donnell

Blood (2018) 131 (8): 911–916.

https://doi.org/10.1182/blood-2017-06-787853

Published: 2018

Includes: Supplemental data

Journal Articles

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

Michelle Lavin, Sonia Aguila, Sonja Schneppenheim, Niall Dalton, Kenneth L. Jones, Jamie M. O’Sullivan, Niamh M. O’Connell, Kevin Ryan, Barry White, Mary Byrne, Marie Rafferty, Mairead M. Doyle, Margaret Nolan, Roger J. S. Preston, Ulrich Budde, Paula James, Jorge Di Paola, James S. O’Donnell

Blood (2017) 130 (21): 2344–2353.

https://doi.org/10.1182/blood-2017-05-786699

Published: 2017

Includes: Supplemental data

Journal Articles

A Runx1 Interactome Identifies Novel Hematopoietic Enhancers

Judith Marsman, PhD, Amarni L Thomas, MSc, Motomi Osato, MD PhD, Justin M O'Sullivan, PhD, Julia A Horsfield, PhD

Blood (2016) 128 (22): 726.

https://doi.org/10.1182/blood.V128.22.726.726

Published: 2016

Journal Articles

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Michelle Lavin, MB FRCPath, Sonia Aguila, PhD, Sonja Schneppenheim, MD, Niall Dalton, BSc, Jamie M O'Sullivan, PhD, Niamh M O'Connell, MB, FRCPath, PhD, Kevin M. Ryan, MB, Mary Byrne, MSc, Margaret Nolan, BSc, Roger Preston, PhD, Ulrich Budde, MD, Paula D. James, MD, Jorge Di Paola, MD, James S O'Donnell, MD PhD

Blood (2016) 128 (22): 873.

https://doi.org/10.1182/blood.V128.22.873.873

Published: 2016

Journal Articles

N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance

Alain Chion, Jamie M. O’Sullivan, Clive Drakeford, Gudmundur Bergsson, Niall Dalton, Sonia Aguila, Soracha Ward, Padraic G. Fallon, Teresa M. Brophy, Roger J. S. Preston, Lauren Brady, Orla Sheils, Michael Laffan, Thomas A. J. McKinnon, James S. O’Donnell

Blood (2016) 128 (15): 1959–1968.

https://doi.org/10.1182/blood-2016-04-709436

Published: 2016

Includes: Supplemental data

Journal Articles

Emerging roles for hemostatic dysfunction in malaria pathogenesis

Jamie M. O’Sullivan, Roger J. S. Preston, Niamh O’Regan, James S. O’Donnell

Blood (2016) 127 (19): 2281–2288.

https://doi.org/10.1182/blood-2015-11-636464

Published: 2016

Journal Articles

A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria

Niamh O’Regan, Kristina Gegenbauer, Jamie M. O’Sullivan, Sanaz Maleki, Teresa M. Brophy, Niall Dalton, Alain Chion, Padraic G. Fallon, Georges E. Grau, Ulrich Budde, Owen P. Smith, Alister G. Craig, Roger J. S. Preston, James S. O’Donnell

Blood (2016) 127 (9): 1192–1201.

https://doi.org/10.1182/blood-2015-07-654921

Published: 2016

Includes: Supplemental data

Journal Articles

Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis

Rachel T. McGrath, Maartje van den Biggelaar, Barry Byrne, Jamie M. O’Sullivan, Orla Rawley, Richard O’Kennedy, Jan Voorberg, Roger J. S. Preston, James S. O’Donnell

Blood (2013) 122 (25): 4107–4110.

https://doi.org/10.1182/blood-2013-04-496851

Published: 2013

Journal Articles

Neutrophil myeloperoxidase regulates T-cell−driven tissue inflammation in mice by inhibiting dendritic cell function

Dragana Odobasic, A. Richard Kitching, Yuan Yang, Kim M. O’Sullivan, Ruth C. M. Muljadi, Kristy L. Edgtton, Diana S. Y. Tan, Shaun A. Summers, Eric F. Morand, Stephen R. Holdsworth

Blood (2013) 121 (20): 4195–4204.

https://doi.org/10.1182/blood-2012-09-456483

Published: 2013

Includes: Supplemental data

NARROW

Targeted Inhibition of Phosphodiesterase (PDE) 4 As a Novel Therapy to Increase Endothelial Cell cAMP and Trigger Weibel Palade Body Exocytosis

Primary Myeloma Cell Induced Von Willebrand Factor Release from the Endothelium Is Mediated By VEGF and Attenuated By Heparin

The relationship between ABO blood group, von Willebrand factor, and primary hemostasis

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib

von Willebrand factor promotes wound healing

Increased galactose expression and enhanced clearance in patients with low von Willebrand factor

Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function

Defining the Molecular Mechanisms through Which the Macrophage Galactose Lectin (MGL) Receptor Regulates Von Willebrand Factor Clearance

Site-Directed Pegylation at Specific Sites Significantly Prolongs the Half-Life of A1A2A3-VWF By Markedly Attenuating LRP1-Mediated Clearance

The Low Von Willebrand Factor in Ireland Cohort Study - Defining Optimal Management for Procedures in Patients with Low VWF (30-50 IU/dL)

Platelets in malaria pathogenesis

A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance

Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels

A Runx1 Interactome Identifies Novel Hematopoietic Enhancers

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance

Emerging roles for hemostatic dysfunction in malaria pathogenesis

A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria

Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis

Neutrophil myeloperoxidase regulates T-cell−driven tissue inflammation in mice by inhibiting dendritic cell function

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only